Altay Therapeutics, Inc. SBIR Phase I Award, September 2022
A SBIR Phase I contract was awarded to Altay Therapeutics Inc in September, 2022 for $299,591.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Is a
Award Amount (USD)
299,591
0
Government Branch
Date Awarded
September 1, 2022
0
End Date
August 31, 2023
0
SBIR/STTR Award Recipient
Contract Number (US Government)
1R43AR081195-01
0
Award Phase
Phase I
0
Award Type
SBIR
0
Official Website
Find more entities like Altay Therapeutics, Inc. SBIR Phase I Award, September 2022
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
